COVID-19: Dialysis Machine Makers Respond To Surge In Demand

Baxter and Fresenius are taking extraordinary steps to respond to the flood of COVID-19 patients requiring continuous renal replacement therapy.

Intensive care infusion pump adjusted by a doctor hand

The leading suppliers of continuous renal replacement therapy are responding to a surge in demand from COVID-19 patients.

Many COVID-19 patients need continuous renal replacement therapy (CRRT) due to acute kidney injury caused by infection. Baxter and Fresenius’ NxStage division are the two leading manufacturers of CRRT equipment....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

More from Medtech Insight